Which renal transplant patients should receive cytomegalovirus immune globulin? A cost-effectiveness analysis

Joel Tsevat, David R. Snydman, Stephen G. Packer, Isabelle Durand-Zaleski, Barbara G. Werner, Andrew S. Levey

Producción científica: Articlerevisión exhaustiva

42 Citas (Scopus)

Huella

Profundice en los temas de investigación de 'Which renal transplant patients should receive cytomegalovirus immune globulin? A cost-effectiveness analysis'. En conjunto forman una huella única.

Medicine and Dentistry

Nursing and Health Professions

Immunology and Microbiology